• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inventiva S.A. ADR (NQ: IVA )

    2.651 -0.009 (-0.33%)
    Streaming Delayed Price Updated: 10:40 AM EST, Nov 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Inventiva S.A. ADR

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?
    Inventiva secures €94.1M in financing, potentially reaching €348M, to fund the Phase 3 NATiV3 trial for lanifibranor in NASH. Leadership changes include new chairman and director appointments. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Where Inventiva Stands With Analysts
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Gold Falls Over 1%; HilleVax Shares Plunge
    Via Benzinga
    Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Dow Turns Lower; Myomo Shares Jump
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Is Inventiva's Stock Trading Higher on Monday?
    Inventiva's Lanifibranor improves cardiometabolic health in MASH/NASH patients. It lowers fasting glucose, reduces cardiovascular risk, and increases adiponectin levels. Weight gain correlates with... 
    Via Benzinga
    Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
    Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
    Via The Motley Fool
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Is Liver Disease-Focused Inventiva Stock Trading Lower Today?
    Inventiva announces a voluntary pause in NATiV3 Phase 3 trial of lanifibranor for NASH due to a treatment-related SUSAR. Screening and randomization halted temporarily. 
    Via Benzinga
    Why The Trade Desk Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
    Shares of The Trade Desk, Inc. (NASDAQ: TTD) shares rose sharply in today’s pre-market trading after the company reported mixed fourth-quarter financial results< 
    Via Benzinga
    Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of DoorDash, Inc. (NASDAQ: DASH) fell sharply in today’s session as the company reported mixed financial results for its fourth quarter. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Yelp Reports Q4 Results, Joins Roku, Dropbox And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    U.S. stock futures were mixed this morning, with the Nasdaq futures trading higher by around 100 points on Friday. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For September 28, 2023
    Companies Reporting Before The Bell • CarMax (NYSE:KMX) is projected to report quarterly earnings at $0.78 per share on revenue of $7.03 billion. 
    Via Benzinga
    Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
    Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar on clinical outcomes in patients with compensated cirrhosis due... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
    Gainers EdtechX Holdings Acquisition Corp. II (NASDAQ: EDTX) shares gained 139.8% to $26.54 in pre-market trading. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Dow Falls Over 100 Points; US Producer Prices Drop In May
    U.S. stocks traded mixed this morning, with Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.32% to 34,101.52 while the NASDAQ rose 0.16%... 
    Via Benzinga
    PLUG Stock Alert: Plug Power Announces New Avina Deal
    Plug Power (PLUG) stock is on the move Wednesday after the EV charging company announced a deal with Avina Clean Hydrogen. 
    Via InvestorPlace
    Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.